Carret Asset Management LLC Decreases Stock Position in Colgate-Palmolive (NYSE:CL)

Carret Asset Management LLC reduced its position in Colgate-Palmolive (NYSE:CLFree Report) by 6.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,318 shares of the company’s stock after selling 1,002 shares during the quarter. Carret Asset Management LLC’s holdings in Colgate-Palmolive were worth $1,393,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently made changes to their positions in the stock. Intact Investment Management Inc. grew its position in shares of Colgate-Palmolive by 11,514.3% in the fourth quarter. Intact Investment Management Inc. now owns 81,300 shares of the company’s stock valued at $7,391,000 after purchasing an additional 80,600 shares in the last quarter. Diamond Hill Capital Management Inc. purchased a new position in shares of Colgate-Palmolive in the fourth quarter valued at $348,718,000. LBP AM SA grew its position in shares of Colgate-Palmolive by 36.4% in the fourth quarter. LBP AM SA now owns 241,828 shares of the company’s stock valued at $21,985,000 after purchasing an additional 64,550 shares in the last quarter. Integras Partners LLC purchased a new position in shares of Colgate-Palmolive in the fourth quarter valued at $2,596,000. Finally, Madison Investment Advisors LLC purchased a new position in shares of Colgate-Palmolive in the fourth quarter valued at $9,479,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Raymond James reiterated an “outperform” rating and issued a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. UBS Group dropped their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Royal Bank of Canada reissued a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Piper Sandler dropped their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Finally, Morgan Stanley dropped their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus target price of $101.61.

View Our Latest Research Report on CL

Colgate-Palmolive Trading Down 0.4 %

NYSE CL opened at $90.41 on Friday. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The stock has a 50-day moving average of $89.03 and a 200-day moving average of $94.93. The firm has a market cap of $73.37 billion, a PE ratio of 25.69, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the firm posted $0.87 earnings per share. As a group, sell-side analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.